A San Francisco start-up could soon help you kick smoking for good. They're using tech to transform the traditional nicotine patch.
“Over 550 Americans die every year from smoking,” said Guy Guidipirro, founder of Chrono Therapeutics. “Ninety percent of all lung cancers are caused by cigarette smoking, so we really can make a difference."
Biotech start-up Chrono Therapeutics in Hayward believes a device is a key; you wear it like a transdermal nicotine patch but it's really a tiny computer that regulates the dosage.
"We've combined smart drug delivery where we've timed the delivery of the nicotine to deal with the patients or the consumers' cravings,” said Dr. Patrick Ruane, Sr. Vice President of R&D at Chrono Therapeutics.
So people get more nicotine when needed, less when not.
"We've actually built a sensor into the device," said Dr. Ruane. It talks to your smartphone. It knows if you change to a fresh patch or not.
"You will get a message, or your family members if you decided to include them in the journey, they will get a message going, ‘Hey, don't forget to put in a new cartridge'," said Dr. Ruane.
Investors are so impressed with the early trial results that Chrono Therapeutics raised $48 million to fund the project. The company says now they can go forward with large-scale trials starting next year.
Meanwhile, testing continues. Human skin is used to measure the transfer rates of various skin types. There are a lot of variables still being confirmed but the work to help solve one of the world’s most pressing problems is making progress.
"If you can find a better way to help people quit smoking, you could essentially eradicate lung cancer and could save millions of lives globally,” said Guidipirro.
Copyright 2016 WFMY